ArticleCEN case reports2025
Light chain proximal tubulopathy in Sjögren syndrome: the critical role of tubular function tests in revealing a hidden threat.
Article in CEN case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A 65-year-old female patient with Sjögren syndrome (SJS) and tubulointerstitial nephritis (TIN) confirmed by kidney biopsy results 7 years previously presented to our department with progressive kidney function deterioration. Laboratory findings revealed increased serum creatinine level accompanied with deterioration of tubular function. Although she already had signs of proximal tubular dysfunction due to TIN from 7 years before, deterioration of the proximal tubule related parameters was particularly prominent. Owing to the substantial increase in the IgG level, monoclonal gammopathy was considered. Subsequent immunoelectrophoresis of the serum and urine revealed the presence of monoclonal IgG-κ. A repeat kidney biopsy revealed crystalline inclusions in the proximal tubules that tested positive for κ light chain. Along with findings from the bone marrow biopsy, this led to the diagnosis of light chain proximal tubulopathy (LCPT) secondary to multiple myeloma. Chemotherapy was initiated promptly which resulted in stabilization of renal function and improvement of tubular function. Vigilant monitoring of the tubular function is essential for patients with SJS. Deterioration of proximal tubule parameters, especially when accompanied by increased IgG levels, should prompt the investigation of monoclonal gammopathy and the consideration of kidney biopsy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.